Atorvastatin monotherapy and combination therapy in the treatment of severe hypercholesterolema

T Heinonen, D Black - Atherosclerosis, 1995 - elibrary.ru
Atorvastatin, a synthetic HMG-CoA reductase inhibitor (HMGRI), has demonstrated
significant lipid-lowering effects in previous clinical trials. This ongoing, open-label …
被引用次数：4 相关文章

Atorvastatin monotherapy and combination therapy in the treatment of severe hypercholesterolema

T Heinonen, D Black - Atherosclerosis, 1995 - infona.pl
Atorvastatin, a synthetic HMG-CoA reductase inhibitor (HMGRI), has demonstrated
significant lipid-lowering effects in previous clinical trials. This ongoing, open-label …

[引用][C] Atorvastatin monotherapy and combination therapy in the treatment of severe hypercholesterolemia

T Heinonen, D Black - Atherosclerosis, 1995 - Elsevier